Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6057.0000
30.50
(
0.51
%)
NSE
Sep 15, 2025
15:31 PM
Volume:
152.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
25 Aug 2022
6057.00
0.51%
DIVI' S LAB
Buy:
Divi's Laboratories Ltd.
by
Geojit BNP Paribas
Target: 4006
Target
Geojit BNP Paribas
Deven Choksey released a Accumulate report for Divi's Laboratories Ltd. with a price target of 6499.0 on 29 Aug, 2025.
More from Divi's Laboratories Ltd.
Recommended
IPO market buzz: Five new issues, eleven listings this week
|
15 Sep 2025, 04:32PM
Market closes lower, Tata Tech to buy Germany-based ES-Tec Group for €75 million
Trendlyne Marketwatch |
15 Sep 2025, 04:03PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022